NCT07471451 Evolution of Masticatory Function, Orofacial Functions and Quality of Life of Patients Treated for Cancers of the Upper Aerodigestive Tract, Rehabilitated by Maxillofacial Prostheses.
| NCT ID | NCT07471451 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Clermont-Ferrand |
| Condition | Head and Neck Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-05-20 |
| Primary Completion | 2030-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-05-20 with a primary completion date of 2030-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a follow-up study of masticatory function, orofacial functions, and quality of life in patients with a history of upper aerodigestive tract cancer who have undergone rehabilitation with maxillofacial prostheses. The main objective of this study is to evaluate changes in masticatory function during a prosthetic rehabilitation program in patients with a history of upper aerodigestive tract cancer.
Eligibility Criteria
Inclusion Criteria: * Adult patient who has given their consent * Patient with a history of upper aerodigestive tract cancer * Cooperative patient * Patient affiliated with a Social Security scheme * Patient capable of understanding and participating in the study * Patient not allergic to the foods being tested Exclusion Criteria: * Minors * Patients treated in the maxillofacial prosthetics clinic of the Odontology Department at Estaing University Hospital in Clermont Ferrand who do not require prosthetic rehabilitation * Patients who are unwilling to participate in the study, particularly in attending the various follow-up sessions * Patients who do not have a good command of written and spoken French * Patients under guardianship, curatorship, or judicial protection * Pregnant or breastfeeding patients * Patients receiving enteral or parenteral nutrition * Patients who have been diagnosed with a recurrence of their cancer and whose prognosis is life-threatening. * Patients with cognitive impairment
Contact & Investigator
Cindy BATISSE LANCE
PRINCIPAL INVESTIGATOR
CHU de Clermont-Fd
Frequently Asked Questions
Who can join the NCT07471451 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Head and Neck Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07471451 currently recruiting?
Yes, NCT07471451 is actively recruiting participants. Contact the research team at promo_interne_drci@chu-clermontferrand.fr for enrollment information.
Where is the NCT07471451 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France.
Who is sponsoring the NCT07471451 clinical trial?
NCT07471451 is sponsored by University Hospital, Clermont-Ferrand. The principal investigator is Cindy BATISSE LANCE at CHU de Clermont-Fd. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.